Cancer cells and cancer-associated fibroblasts, inspired by the Review on p792.

Costimulatory domains in chimeric antigen receptors, inspired by the Review on p715.

Selecting immunotherapy regimens for lung cancer, inspired by the Review on p625.

Intratumoural delivery of immunotherapies, inspired by the Review on p558.

Biomarker-based selection of targeted therapies for patients with gastric or gastro-oesophageal junction cancers, inspired by the Review on p473.

Cancer therapies based on targeted protein degradation, inspired by the Review on p401.

Targeting tumours with antibody–drug conjugates, inspired by the Review on p327.

COVID-19 vaccination of oncology clinical trial participants, inspired by the Perspective on p313.

Single-cell analysis of tumour immunology, inspired by the Perspective on p244.

Nuclear export is often dysregulated in cancer; therapeutic strategies to target this process are discussed in the Review on p152.

Clonal heterogeneity in multiple myeloma requires effective therapies, a topic discussed in the Review on p71.

‘ROS1 fusions in cancer’, by Simon Bradbrook, inspired by the Review on p35.